Artivion, Inc. (AORT) revenue by segment
AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/305% below fair value
$18.54+0.27 (+1.48%)
Close on Nov 18, 2026Market cap $903.94MP/E –Yield –
Doanh thu theo bộ phận của Artivion, Inc.
Theo bộ phận kinh doanh
| Doanh thu | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical devices | $345.83M | $290.23M | $261.19M | $230.35M | $221.60M | $179.30M | $197.25M | $187.39M | $119.63M | $113.99M | 78.4% | +19.2% |
| North America | $221.74M | $197.94M | $187.60M | $167.54M | $157.88M | – | – | – | – | – | 50.2% | +12.0% |
| EMEA | $151.37M | $131.52M | $114.81M | $104.12M | $109.08M | – | – | – | – | – | 34.3% | +15.1% |
| Preservation services | $95.51M | $98.31M | $92.82M | $83.44M | $77.24M | $73.93M | $78.98M | $75.45M | $70.07M | $66.39M | 21.6% | -2.9% |
| APAC | $44.25M | $37.20M | $33.58M | $27.97M | $21.70M | – | – | – | – | – | 10.0% | +18.9% |
| LATAM | $23.97M | $21.88M | $18.01M | $14.16M | $10.18M | – | – | – | – | – | 5.4% | +9.6% |
Theo sản phẩm hoặc dịch vụ
| Doanh thu | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Products | $345.83M | $290.23M | $261.19M | $230.35M | $221.60M | $179.30M | $197.25M | $187.39M | $119.63M | $113.99M | 78.4% | +19.2% |
| Aortic stent grafts | $159.37M | $123.08M | $107.47M | $92.75M | $85.39M | $61.66M | $64.97M | $63.34M | – | – | 36.1% | +29.5% |
| On-X | $101.74M | $83.98M | $74.53M | $63.90M | $57.36M | $48.05M | $50.10M | $44.83M | $37.04M | $34.23M | 23.1% | +21.1% |
| Preservation services | $95.51M | $98.31M | $92.82M | $83.44M | $77.24M | $73.93M | $78.98M | $75.45M | $70.07M | $66.39M | 21.6% | -2.9% |
| Surgical sealants | $76.60M | $73.90M | $68.02M | $65.38M | $70.71M | $62.07M | $68.61M | – | – | – | 17.4% | +3.7% |
| Other | $8.11M | $9.27M | $11.17M | $8.32M | $8.13M | $7.52M | $13.57M | – | – | – | 1.8% | -12.5% |
| International distributors | – | – | – | $47.60M | $41.05M | $34.43M | $40.43M | $36.99M | $30.81M | $32.04M | – | – |
| Domestic hospitals | – | – | – | $158.13M | $150.30M | $137.81M | $144.54M | $138.43M | $128.24M | $123.89M | – | – |
| International hospitals | – | – | – | $105.07M | $106.64M | $80.52M | $85.24M | $81.20M | $23.79M | $16.62M | – | – |
| CardioGenesis cardiac laser therapy | – | – | – | $2.98M | $850.00K | $464.00K | $6.02M | $6.22M | $6.87M | $7.84M | – | – |
| PerClot | – | – | – | – | – | $2.88M | $3.80M | $3.77M | $3.53M | $4.02M | – | – |
| Cardiac tissues | – | – | – | – | – | $37.89M | $40.88M | $35.68M | $32.51M | $29.70M | – | – |
| Vascular tissues | – | – | – | – | – | $35.85M | $38.10M | $39.76M | $37.56M | $36.69M | – | – |
| PhotoFix | – | – | – | – | – | $4.17M | $3.75M | $2.58M | $2.12M | $1.87M | – | – |
| BioGlue | – | – | – | – | – | $62.07M | $68.61M | $66.66M | $65.94M | – | – | – |
| NeoPatch | – | – | – | – | – | $183.00K | – | – | – | – | – | – |
| JOTEC (including NEXUS) | – | – | – | – | – | – | $64.97M | $63.34M | $4.14M | – | – | – |
| Medical devices | – | – | – | – | – | – | $197.25M | $187.39M | $119.63M | $113.99M | – | – |
| BioGlue And BioFoam | – | – | – | – | – | – | – | $66.66M | $65.94M | $63.46M | – | – |
| HeRO Graft | – | – | – | – | – | – | – | – | – | $2.33M | – | – |
| ProCol | – | – | – | – | – | – | – | – | – | $218.00K | – | – |
Theo khu vực
| Doanh thu | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International | $227.26M | $198.54M | $174.52M | $152.68M | $147.69M | $114.95M | $125.67M | $118.19M | $54.60M | $48.65M | 51.5% | +14.5% |
| United States | $214.08M | $189.99M | $179.49M | $161.11M | $151.15M | $138.27M | $150.55M | $144.65M | $135.10M | $131.73M | 48.5% | +12.7% |
Lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K, 10-Q của Artivion (XBRL). Số quý 4 bằng cả năm tài chính trừ chín tháng đầu. Tên bộ phận giữ theo cách công ty tự đặt và có thể đổi khi công ty tái cấu trúc. Tab KPI hiện các bộ phận này cạnh chỉ số vận hành của Artivion, kèm đầy đủ lịch sử, biểu đồ và liên kết tới từng hồ sơ.
See a number that looks wrong?